3 hours Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of “Buy” from BrokeragesMarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) has been given a consensus rating of “Buy” by the nine ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recomme…
Biotech · Nasdaq 100 · Science
X